store at low temperature | Powder: -20°C for 3 years | In solvent: -80°C for 1 year
Carabersat (SB 204269)是一种新型有效的抗惊厥和抗癫痫试剂。
产品描述 | Carabersat(SB 204269) is a novel and effective anticonvulsant and antiepileptic agent. |
靶点活性 | Forebrain membranes:53 nM (Kd,mouse), Forebrain membranes:40 nM (Kd,rat), Forebrain membranes:7.3 (pKi,rat) |
体外活性 | [3H]Carabersat ([3H]SB 204269) binds to rat forebrain membranes with moderate affinity (Kd 40 nM) and pKi values of 7.3[1]. In mouse forebrain membranes, Carabersat is able to bind, and the binding is saturable and stereospecific, with a Kd of 53 nM. The labeled [3H]Carabersat produces a Kd of 32 nM[2]. Carabersat (SB-204269, 1-100 μM) has no effect on Na+ current in cultured hippocampal neurons. It also shows no effect on action potential discharges evoked by elevating external K+[4]. Structurally related to the benzopyran ATP-sensitive potassium channel (KATP) opener cromakalim, Carabersat (SB-204269) has opposite stereochemistry, and its mechanism of action is not thought to involve KATP[3]. |
体内活性 | Significantly elevating anticonvulsant activity in mice, Carabersat (5b) has been observed[1]. |
别名 | SB 204269 |
分子量 | 357.38 |
分子式 | C20H20FNO4 |
CAS No. | 184653-84-7 |
store at low temperature | Powder: -20°C for 3 years | In solvent: -80°C for 1 year
对于不同动物的给药剂量换算,您也可以参考 更多...
请在以下方框中输入您的动物实验信息后点击计算,可以得到母液配置方法和体内配方的制备方法: 比如您的给药剂量是10 mg/kg,每只动物体重20 g,给药体积100 μL,一共给药动物10 只,您使用的配方为5% DMSO+30% PEG300+5% Tween 80+60% ddH2O。那么您的工作液浓度为2 mg/mL。
母液配置方法:2 mg 药物溶于 50 μL DMSO (母液浓度为 40 mg/mL), 如您需要配置的浓度超过该产品的溶解度,请先与我们联系。
体内配方的制备方法:取 50 μL DMSO 主液,加入 300 μL PEG300, 混匀澄清,再加 50 μL Tween 80,混匀澄清,再加 600 μL ddH2O, 混匀澄清。
您可能有的问题的答案可以在抑制剂处理说明中找到,包括如何准备库存溶液,如何存储产品,以及基于细胞的分析和动物实验需要特别注意的问题。
Carabersat 184653-84-7 Others SB 204269 Inhibitor inhibitor inhibit